ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,235.48
-0.60%
US Tech 100
18,058.24
-1.09%
Dow Jones
38,111.48
-0.86%
Brent Oil
81.935
-1.73%
Bitcoin
68,540.73
1.42%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/30/20244:00PMEdgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:CRSRCorsair Gaming Inc
05/30/20244:00PMBusiness WirePalantir Selected by Chief Digital and Artificial Intelligence Office (CDAO) to Participate in Scaling Data Analytics and AI Capabilities Across the Department of Defense in Support of CJADC2 StrategyNYSE:PLTRPalantir Technologies Inc
05/30/20244:00PMBusiness WireTaskUs to Present at William Blair 44th Annual Growth Stock Conference on June 5, 2024NASDAQ:TASKTaskUs Inc
05/30/20244:00PMGlobeNewswire Inc.Immunocore to present at the Jefferies Global Healthcare ConferenceNASDAQ:IMCRImmunocore Holdings PLC
05/30/20244:00PMGlobeNewswire Inc.Highest Performances Holdings Inc. Announces Unaudited Financial Results for the First Half of the Fiscal Year 2024NASDAQ:HPHHighest Performances Holdings Inc
05/30/20244:00PMGlobeNewswire Inc.Ultragenyx Announces Positive Top-Line Results from Phase 3 Study of DTX401 Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)NASDAQ:RAREUltragenyx Pharmaceutical Inc
05/30/20244:00PMBusiness WireOncoNano Medicine To Present a Trials in Progress Poster for ON-5001 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
05/30/20244:00PMGlobeNewswire Inc.Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting DeterminationNASDAQ:QLGNQualigen Therapeutics Inc
05/30/20244:00PMBusiness WireSoftchoice Corporation Reports Annual Meeting Voting ResultsTSX:SFTCSoftchoice Corporation
05/30/20243:59PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:VXZiPath Series B S&P 500 VIX MidTerm Futures ETN
05/30/20243:59PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:VXZiPath Series B S&P 500 VIX MidTerm Futures ETN
05/30/20243:59PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:AMJBAlerian Mlp Index ETNs due January 28 2044
05/30/20243:59PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:AMJBAlerian Mlp Index ETNs due January 28 2044
05/30/20243:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NICNicolet Bankshares Inc
05/30/20243:59PMPR Newswire (Canada)Résultats de la vente aux enchères des marchés du carbone du Québec et de la Californie du 22 mai 2024
05/30/20243:57PMBusiness WireKontron introduces the XMC-ETH6
05/30/20243:56PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:BACRPBank of America Corp (PK)
05/30/20243:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:MTXMinerals Technologies Inc
05/30/20243:56PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:AMJBAlerian Mlp Index ETNs due January 28 2044
05/30/20243:56PMBusiness WireStimulation of Sensory Neurons Increases Antibody Responses
05/30/20243:56PMPR Newswire (Canada)La Commission de l'intérêt public recommande à l'employeur et à l'AFPC de reprendre immédiatement les négociations collectives afin de conclure une entente pour le groupe Services frontaliers
05/30/20243:56PMBusiness WireAM Best Affirms Credit Ratings of Instituto Nacional de Seguros
05/30/20243:56PMPR Newswire (US)San Antonio: The Coolest Destination Kicks Off Summer with First-Ever River Celebration
05/30/20243:55PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:HASIHannon Armstrong Sustainable Infrastructure Capital Inc
05/30/20243:55PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:VXZiPath Series B S&P 500 VIX MidTerm Futures ETN
05/30/20243:55PMPR Newswire (US)Announcing a Groundbreaking Software Partnership between Expedia Group and KOALA
05/30/20243:54PMAlliance NewsAlliance NewsFragrant Prosperity seeks funding and hunt for acquisition continuesLSE:FPPFragrant Prosperity Holdings Limited
05/30/20243:54PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:VXZiPath Series B S&P 500 VIX MidTerm Futures ETN
05/30/20243:54PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:VXZiPath Series B S&P 500 VIX MidTerm Futures ETN
05/30/20243:53PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DKSDicks Sporting Goods Inc

Your Recent History

USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
BLEG
Branded Legacy (PK)
USOTC
TPTW
TPT Global Tech (CE)
NASDAQ
FFIE
Faraday Future Intellige...
USOTC
KEGS
1812 Brewing (PK)
USOTC
EPAZ
Epazz (PK)
USOTC
GRLT
Grillit (PK)
USOTC
SPZI
Spooz (PK)
NASDAQ
AGBA
AGBA
USOTC
AHRO
Authentic (CE)
USOTC
AFFU
Affluence (PK)
USOTC
ENZC
Enzolytics (PK)
NASDAQ
RNAZ
TransCode Therapeutics
USOTC
NSAV
Net Savings Link (PK)
NASDAQ
IOVA
Iovance Biotherapeutics
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved